[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]

December 2018 - April 2016

Decade

Year

Issue

August 2016, Vol 1, No. 5, Pages 503-623

In This Issue of JAMA Cardiology

Highlights

Abstract Full Text
free access
JAMA Cardiol. 2016;1(5):503. doi:10.1001/jamacardio.2015.0026
Original Investigation

Characteristics and Outcomes of Adult Outpatients With Heart Failure and Improved or Recovered Ejection Fraction

Abstract Full Text
free access
JAMA Cardiol. 2016;1(5):510-518. doi:10.1001/jamacardio.2016.1325

This cohort study compares the clinical characteristics and outcomes of heart failure patients with reduced vs preserved vs reduced then recovered ejection fraction.

Six-Year Change in High-Sensitivity Cardiac Troponin T and Risk of Subsequent Coronary Heart Disease, Heart Failure, and Death

Abstract Full Text
free access
JAMA Cardiol. 2016;1(5):519-528. doi:10.1001/jamacardio.2016.0765

This cohort study uses ARIC study data to examine the association between 6-year change in high-sensitivity cardiac troponin T and incident coronary heart disease, heart failure, and all-cause mortality.

Survival After Coronary Artery Bypass Grafting in Patients With Preoperative Heart Failure and Preserved vs Reduced Ejection Fraction

Abstract Full Text
free access
JAMA Cardiol. 2016;1(5):530-538. doi:10.1001/jamacardio.2016.1465

This cohort study uses Swedish national registry data to compare mortality after coronary artery bypass grafting in patients with preoperative heart failure and reduced vs preserved ejection fraction.

Prevalence and Outcomes of Anemia and Hematinic Deficiencies in Patients With Chronic Heart Failure

Abstract Full Text
free access
JAMA Cardiol. 2016;1(5):539-547. doi:10.1001/jamacardio.2016.1161

This study investigates the epidemiology of anemia and iron deficiency in a broad range of patients referred to a cardiology clinic with suspected heart failure.

Association of Fibroblast Growth Factor 23 With Atrial Fibrillation in Chronic Kidney Disease, From the Chronic Renal Insufficiency Cohort Study

Abstract Full Text
free access
JAMA Cardiol. 2016;1(5):548-556. doi:10.1001/jamacardio.2016.1445

This cohort study investigates the association of fibroblast growth factor 23 with atrial fibrillation in chronic kidney disease.

Effect of Cyclosporine in Nonshockable Out-of-Hospital Cardiac Arrest: The CYRUS Randomized Clinical Trial

Abstract Full Text
free access
JAMA Cardiol. 2016;1(5):557-565. doi:10.1001/jamacardio.2016.1701

This randomized clinical trial compares the effect of cyclosporine vs usual care on multiorgan failure in patients with out-of-hospital cardiac arrest.

Cardiovascular Events in a Physical Activity Intervention Compared With a Successful Aging Intervention: The LIFE Study Randomized Trial

Abstract Full Text
free access
JAMA Cardiol. 2016;1(5):568-574. doi:10.1001/jamacardio.2016.1324

This study evaluates whether cardiovascular morbidity and mortality would be reduced in participants in a long-term physical activity program.

Continuous Dose-Response Association Between Sedentary Time and Risk for Cardiovascular Disease: A Meta-analysis

Abstract Full Text
free access
JAMA Cardiol. 2016;1(5):575-583. doi:10.1001/jamacardio.2016.1567

This meta-analysis of cohort studies investigates the dose-response association between sedentary time and risk for cardiovascular disease in adults.

Evaluation of Flow After Transcatheter Aortic Valve Replacement in Patients With Low-Flow Aortic Stenosis: A Secondary Analysis of the PARTNER Randomized Clinical Trial

Abstract Full Text
free access
JAMA Cardiol. 2016;1(5):584-592. doi:10.1001/jamacardio.2016.0759

This study evaluates left-ventricular stroke volume index after transcatheter aortic valve replacement in participants in the PARTNER randomized clinical trial who had severe aortic stenosis.

Brief Report

Recent Trends in Cardiovascular Mortality in the United States and Public Health Goals

Abstract Full Text
free access
JAMA Cardiol. 2016;1(5):594-599. doi:10.1001/jamacardio.2016.1326

This study evaluates Centers for Disease Control and Prevention data on changes in mortality rates for cardiovascular diseases and cancer from 2000 to 2014.

A Digital Health Intervention to Lower Cardiovascular Risk: A Randomized Clinical Trial

Abstract Full Text
free access
JAMA Cardiol. 2016;1(5):601-606. doi:10.1001/jamacardio.2016.1035

This randomized clinical trial assesses whether a digital health intervention designed to change diet and physical activity improves the risk for myocardial infarction among a South Asian population.

Research Letter

Cardiac Stress Testing and the Radiotracer Supply Chain: Nuclear Freeze

Abstract Full Text
free access
JAMA Cardiol. 2016;1(5):616-617. doi:10.1001/jamacardio.2016.1680

This article discusses the clinical effects of a 6-month shortage of technetium Tc 99m, a radiotracer used in cardiac stress testing.

Trends in Palliative Care Use in Veterans With Severe Heart Failure Using a Large National Cohort

Abstract Full Text
free access
JAMA Cardiol. 2016;1(5):617-619. doi:10.1001/jamacardio.2016.1687

This epidemiology study uses Veteran Affairs External Peer Review data to characterize trends in the use of palliative care by patients with severe heart failure between 2007 and 2013.

Viewpoint

The ABCDs of Lifestyle Counseling

Abstract Full Text
free access
JAMA Cardiol. 2016;1(5):505-506. doi:10.1001/jamacardio.2016.1419

This Viewpoint proposes an “ABCD” framework for lifestyle counseling: Assess readiness for change, identify potential Barriers, encourage patients to Commit to goals, and help them Demonstrate progress.

Editorial

Heart Failure—A New Phenotype Emerges

Abstract Full Text
free access
JAMA Cardiol. 2016;1(5):507-509. doi:10.1001/jamacardio.2016.1356
Invited Commentary

Biomarkers to Predict Risk in Apparently Well Populations

Abstract Full Text
free access
JAMA Cardiol. 2016;1(5):528-529. doi:10.1001/jamacardio.2016.1019

Cyclosporine for Reperfusion Injury After Cardiac Arrest: Too Little Too Late?

Abstract Full Text
JAMA Cardiol. 2016;1(5):566-567. doi:10.1001/jamacardio.2016.1822

Low-Flow Aortic Stenosis After Transcutaneous Aortic Valve Replacement: It’s All About the Flow

Abstract Full Text
free access
JAMA Cardiol. 2016;1(5):592-593. doi:10.1001/jamacardio.2016.1206

Slowing Progress in Cardiovascular Mortality Rates: You Reap What You Sow

Abstract Full Text
free access
JAMA Cardiol. 2016;1(5):599-600. doi:10.1001/jamacardio.2016.1348
Review

Mineralocorticoid Receptor Antagonists in the Management of Heart Failure and Resistant Hypertension: A Review

Abstract Full Text
has active quiz
JAMA Cardiol. 2016;1(5):607-612. doi:10.1001/jamacardio.2016.1878

This review examines evidence for the use of mineralocorticoid receptor antagonists in the treatment of heart failure and resistant hypertension.

JAMA Cardiology Clinical Challenge

A Young Woman With Recurrent Atrial Fibrillation

Abstract Full Text
free access
JAMA Cardiol. 2016;1(5):613-614. doi:10.1001/jamacardio.2016.0725

An 18-year-old woman was referred to our adult congenital heart disease center for investigation of chest pain and atrial fibrillation. What would you do next?

JAMA Cardiology Patient Page

Aortic Valve Stenosis

Abstract Full Text
free access
JAMA Cardiol. 2016;1(5):623. doi:10.1001/jamacardio.2016.2060
JAMA Cardiology Masthead

JAMA Cardiology

Abstract Full Text
free access
JAMA Cardiol. 2016;1(5):504. doi:10.1001/jamacardio.2015.0027
×